Header Logo

Connection

JORGE E CORTES to Random Allocation

Back to Details
This is a "connection" page, showing publications JORGE E CORTES has written about Random Allocation.
JORGE E CORTES
Connection Strength
0.124
Random Allocation
  1. Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial. Lancet Haematol. 2016 Dec; 3(12):e581-e591.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.